Abstract
Eukaryotic organisms require iron to sustain genome stability, cell proliferation and development. Chromosomes contain telomeres to ensure complete replications and avoid fusions. Numerous evidences reveal that iron can act directly or indirectly on telomere maintenance. In human, disruption of systemic or cellular iron homeostasis is reportedly to cause serious health problems such as iron overload (hereditary hemochromatosis), iron deficiency anemia, carcinogenesis and acceleration of aging process. These processes commonly associate with abnormal telomere length. Additionally, cells containing mutations in iron-containing proteins such as DNA polymerases (Polα, δ, and ɛ), regulator of telomere length 1 (RTEL1) and the small subunit of ribonucleotide reductases (RNRs) have abnormal telomere length. This review briefly summarizes current understandings on iron homeostasis and telomere maintenance in cancer and aging process, followed by discussing their direct and indirect correlation, and the possible regulatory mechanisms.
Similar content being viewed by others
References
Adams Martin A, Dionne I, Wellinger R J, Holm C (2000). The function of DNA polymerase alpha at telomeric G tails is important for telomere homeostasis. Mol Cell Biol, 20(3): 786–796
Addinall S G, Holstein E M, Lawless C, Yu M, Chapman K, Banks A P, Ngo H P, Maringele L, Taschuk M, Young A, Ciesiolka A, Lister A L, Wipat A, Wilkinson D J, Lydall D (2011). Quantitative fitness analysis shows that NMD proteins and many other protein complexes suppress or enhance distinct telomere cap defects. PLoS Genet, 7(4): e1001362
Andrews N C, Schmidt P J (2007). Iron homeostasis. Annu Rev Physiol, 69(1): 69–85
Askree S H, Yehuda T, Smolikov S, Gurevich R, Hawk J, Coker C, Krauskopf A, Kupiec M, McEachern M J (2004). A genome-wide screen for Saccharomyces cerevisiae deletion mutants that affect telomere length. Proc Natl Acad Sci USA, 101(23): 8658–8663
Aubert G, Lansdorp P M (2008). Telomeres and aging. Physiol Rev, 88(2): 557–579
Beaumont C (2010). Multiple regulatory mechanisms act in concert to control ferroportin expression and heme iron recycling by macrophages. Haematologica, 95(8): 1233–1236
Bischoff C, Petersen H C, Graakjaer J, Andersen-Ranberg K, Vaupel J W, Bohr V A, Kølvraa S, Christensen K (2006). No association between telomere length and survival among the elderly and oldest old. Epidemiology, 17(2): 190–194
Brookes M J, Hughes S, Turner F E, Reynolds G, Sharma N, Ismail T, Berx G, McKie A T, Hotchin N, Anderson G J, Iqbal T, Tselepis C (2006). Modulation of iron transport proteins in human colorectal carcinogenesis. Gut, 55(10): 1449–1460
Brown K E, Meleah Mathahs M, Broadhurst K A, Coleman M C, Ridnour L A, Schmidt W N, Spitz D R (2007). Increased hepatic telomerase activity in a rat model of iron overload: a role for altered thiol redox state?. Free Radic Biol Med, 42(2): 228–235
Calado R, Young N (2012). Telomeres in disease. F1000 Med Rep, 4: 8
Carson J L, Adamson, J W (2010). Iron deficiency and heart disease: ironclad evidence?. Hematology, 2010(1): 348–350
Chung M, Chan J A, Moorthy D, Hadar N, Ratichek S J, Concannon TW, Lau J (2013). In Biomarkers for Assessing and Managing Iron Deficiency Anemia in Late-Stage Chronic Kidney Disease: Future Research Needs: Identification of Future Research Needs From. Comparative Effectiveness Review No 83 (Rockville (MD)). www.effectivehealthcare.ahrq.gov/reports/final.cfm
Cong Y S, Wright W E, Shay J W (2002). Human telomerase and its regulation. Microbiol Mol Biol Rev, 66(3): 407–425
Cosme-Blanco W, Shen M F, Lazar A J, Pathak S, Lozano G, Multani A S, Chang S (2007). Telomere dysfunction suppresses spontaneous tumorigenesis in vivo by initiating p53-dependent cellular senescence. EMBO Rep, 8(5): 497–503
de Lange T (2005). Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev, 19(18): 2100–2110
de Lange T (2009). How telomeres solve the end-protection problem. Science, 326(5955): 948–952
de Lange T (2010). Telomere biology and DNA repair: enemies with benefits. FEBS Lett, 584(17): 3673–3674
Denchi E L, de Lange T (2007). Protection of telomeres through independent control of ATM and ATR by TRF2 and POT1. Nature, 448(7157): 1068–1071
Deng Z, Atanasiu C, Burg J S, Broccoli D, Lieberman P M (2003). Telomere repeat binding factors TRF1, TRF2, and hRAP1 modulate replication of Epstein-Barr virus OriP. J Virol, 77(22): 11992–12001
Deng Z, Lezina L, Chen C J, Shtivelband S, So W, Lieberman P M (2002). Telomeric proteins regulate episomal maintenance of Epstein-Barr virus origin of plasmid replication. Mol Cell, 9(3): 493–503
Denic S, Agarwal M M (2007). Nutritional iron deficiency: an evolutionary perspective. Nutrition, 23(7–8): 603–614
Diotti R, Loayza D (2011). Shelterin complex and associated factors at human telomeres. Nucleus, 2(2): 119–135
Dlouhy A C, Outten C E (2013). The iron metallome in eukaryotic organisms. Metal Ions in Life Sciences 12: 241–278
Donate L E, Blasco M A (2011). Telomeres in cancer and ageing. Philos Trans R Soc Lond B Biol Sci, 366(1561): 76–84
Fikus M U, Mieczkowski P A, Koprowski P, Rytka J, Sledziewska-Gójska E, Ciésla Z (2000). The product of the DNA damage-inducible gene of Saccharomyces cerevisiae, DIN7, specifically functions in mitochondria. Genetics, 154(1): 73–81
Fuster J J, Andrés V (2006). Telomere biology and cardiovascular disease. Circ Res, 99(11): 1167–1180
Fyhrquist F, Saijonmaa O, Strandberg T (2013). The roles of senescence and telomere shortening in cardiovascular disease. Nat Rev Cardiol, 10(5): 274–283
Ganz T (2011). Hepcidin and iron regulation, 10 years later. Blood, 117(17): 4425–4433
Ghio A J, Stonehuerner J G, Richards J H, Crissman K M, Roggli V L, Piantadosi C A, Carraway M S (2008). Iron homeostasis and oxidative stress in idiopathic pulmonary alveolar proteinosis: a case-control study. Respir Res, 9(1): 10
Green N S, Mayeux R (2006). The long and short of it: telomeres and the brain. Lancet Neurol, 5(12): 999–1000
Gupta A, Sharma S, Reichenbach P, Marjavaara L, Nilsson A K, Lingner J, Chabes A, Rothstein R, Chang M (2013). Telomere length homeostasis responds to changes in intracellular dNTP pools. Genetics, 193(4): 1095–1105
Hanson E H, Imperatore G, Burke W (2001). HFE gene and hereditary hemochromatosis: a HuGE review. Human Genome Epidemiology. Am J Epidemiol, 154(3): 193–206
Hatcher H C, Singh R N, Torti F M, Torti S V (2009). Synthetic and natural iron chelators: therapeutic potential and clinical use. Future Med Chem, 1: 1643–1670
Heath J L, Weiss J M, Lavau C P, Wechsler D S (2013). Iron deprivation in cancer—potential therapeutic implications. Nutrients, 5(8): 2836–2859
Herbig U, Jobling W A, Chen B P, Chen D J, Sedivy J M (2004). Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a). Mol Cell, 14(4): 501–513
Houben J M, Giltay E J, Rius-Ottenheim N, Hageman G J, Kromhout D (2011). Telomere length and mortality in elderly men: the Zutphen Elderly Study. J Gerontol A Biol Sci Med Sci, 66(1): 38–44
Huang M, Elledge S J (1997). Identification of RNR4, encoding a second essential small subunit of ribonucleotide reductase in Saccharomyces cerevisiae. Mol Cell Biol, 17(10): 6105–6113
Jain S, Sugawara N, Lydeard J, Vaze M, Tanguy Le Gac N, Haber J E (2009). A recombination execution checkpoint regulates the choice of homologous recombination pathway during DNA double-strand break repair. Genes Dev, 23(3): 291–303
Jakupciak J P, Wang W, Barker P E, Srivastava S, Atha D H (2004). Analytical validation of telomerase activity for cancer early detection: TRAP/PCR-CE and hTERT mRNA quantification assay for high-throughput screening of tumor cells. J Mol Diagn, 6(3): 157–165
Jian, J, Pelle E, Huang X (2009). Iron and menopause: does increased iron affect the health of postmenopausal women?. Antioxidants Redox Signal, 11: 2939–2943
Kaplan J, McVey Ward D, Crisp R J, Philpott C C (2006). Irondependent metabolic remodeling in S. cerevisiae. Biochim Biophys Acta, 1763(7): 646–651
Kaur D, Andersen J K (2002). Ironing out Parkinson’s disease: is therapeutic treatment with iron chelators a real possibility?. Aging Cell, 1(1): 17–21
Kawasaki Y, Sugino A (2001). Yeast replicative DNA polymerases and their role at the replication fork. Mol Cells, 12(3): 277–285
Killilea DW, Wong S L, Cahaya H S, Atamna H, Ames B N (2004). Iron accumulation during cellular senescence. Ann N Y Acad Sci, 1019 (1): 365–367
Kim Sh S H, Kaminker P, Campisi J (2002). Telomeres, aging and cancer: in search of a happy ending. Oncogene, 21(4): 503–511
Koziel J E, Fox M J, Steding C E, Sprouse A A, Herbert B S (2011). Medical genetics and epigenetics of telomerase. J Cell Mol Med, 15(3): 457–467
Kozlitina J, Garcia C K (2012). Red blood cell size is inversely associated with leukocyte telomere length in a large multi-ethnic population. PLoS ONE, 7(12): e51046
Kremastinos D T, Farmakis D (2011). Iron overload cardiomyopathy in clinical practice. Circulation, 124(20): 2253–2263
Lamy P J, Durigova A, Jacot W (2014). Iron homeostasis and anemia markers in early breast cancer: Iron and breast cancer. Clin Chim acta, 434: 34–40
Lawen A, Lane D J (2013). Mammalian iron homeostasis in health and disease: uptake, storage, transport, and molecular mechanisms of action. Antioxid Redox Signal, 18: 2473–2507
Le Guen T, Jullien L, Touzot F, Schertzer M, Gaillard L, Perderiset M, Carpentier W, Nitschke P, Picard C, Couillault G, Soulier J, Fischer A, Callebaut I, Jabado N, Londono-Vallejo A, de Villartay J P, Revy P (2013). Human RTEL1 deficiency causes Hoyeraal-Hreidarsson syndrome with short telomeres and genome instability. Hum Mol Genet, 22(16): 3239–3249
Li H, Mapolelo D T, Dingra N N, Naik S G, Lees N S, Hoffman B M, Riggs-Gelasco P J, Huynh B H, Johnson M K, Outten C E (2009). The yeast iron regulatory proteins Grx3/4 and Fra2 form hetero-dimeric complexes containing a [2Fe-2S] cluster with cysteinyl and histidyl ligation. Biochemistry, 48(40): 9569–9581
Lill R (2009). Function and biogenesis of iron-sulphur proteins. Nature, 460(7257): 831–838
Lis E T, O’Neill B M, Gil-Lamaignere C, Chin J K, Romesberg F E (2008). Identification of pathways controlling DNA damage induced mutation in Saccharomyces cerevisiae. DNA Repair (Amst), 7(5): 801–810
Liu L, Berletch J B, Green J G, Pate M S, Andrews L G, Tollefsbol T O (2004). Telomerase inhibition by retinoids precedes cytodifferentiation of leukemia cells and may contribute to terminal differentiation. Mol Cancer Ther, 3(8): 1003–1009
Ludlow A T, Ludlow L W, Roth S M (2013). Do telomeres adapt to physiological stress?. Exploring the effect of exercise on telomere length and telomere-related proteins. Biomed Res Int, 2013: 601368
Ma H, Zhou Z, Wei S, Liu Z, Pooley K A, Dunning A M, Svenson U, Roos G, Hosgood H D 3rd, Shen M, Wei Q (2011). Shortened telomere length is associated with increased risk of cancer: a meta-analysis. PLoS ONE, 6(6): e20466
Mainous A G 3rd, Wright R U, Hulihan M M, Twal W O, McLaren C E, Diaz V A, McLaren G D, Argraves W S, Grant A M (2013). Telomere length and elevated iron: the influence of phenotype and HFE genotype. Am J Hematol, 88(6): 492–496
Marques O, da Silva B M, Porto G, Lopes C (2014). Iron homeostasis in breast cancer. Cancer Lett, 347(1): 1–14
Martínez P, Blasco M A (2011). Telomeric and extra-telomeric roles for telomerase and the telomere-binding proteins. Nat Rev Cancer, 11(3): 161–176
Miller J L (2013). Iron deficiency anemia: a common and curable disease. Cold Spring Harb Perspect Med, 3(7). pii: a011866
Moslehi J, DePinho R A, Sahin E (2012). Telomeres and mitochondria in the aging heart. Circ Res, 110(9): 1226–1237
Mourkioti F, Kustan J, Kraft P, Day J W, Zhao M M, Kost-Alimova M, Protopopov A, DePinho R A, Bernstein D, Meeker A K, Blau H M (2013). Role of telomere dysfunction in cardiac failure in Duchenne muscular dystrophy. Nat Cell Biol, 15(8): 895–904
Neumann A A, Watson CM, Noble J R, Pickett H A, Tam P P, Reddel R R (2013). Alternative lengthening of telomeres in normal mammalian somatic cells. Genes Dev, 27(1): 18–23
Njajou O T, Hsueh W C, Blackburn E H, Newman A B, Wu S H, Li R, Simonsick E M, Harris T M, Cummings S R, Cawthon R M, the Health ABC study (2009). Association between telomere length, specific causes of death, and years of healthy life in health, aging, and body composition, a population-based cohort study. J Gerontol A Biol Sci Med Sci, 64(8): 860–864
Nordlund P, Reichard P (2006). Ribonucleotide reductases. Annu Rev Biochem, 75(1): 681–706
Oh H, Wang S C, Prahash A, Sano M, Moravec C S, Taffet G E, MichaelL H, Youker K A, Entman M L, Schneider M D (2003). Telomere attrition and Chk2 activation in human heart failure. Proc Natl Acad Sci USA, 100(9): 5378–5383
Ohya T, Kawasaki Y, Hiraga S, Kanbara S, Nakajo K, Nakashima N, Suzuki A, Sugino A (2002). The DNA polymerase domain of pol (epsilon) is required for rapid, efficient, and highly accurate chromosomal DNA replication, telomere length maintenance, and normal cell senescence in Saccharomyces cerevisiae. J Biol Chem, 277(31): 28099–28108
Oliveira L, Drapier J C (2000). Down-regulation of iron regulatory protein 1 gene expression by nitric oxide. Proc Natl Acad Sci USA, 97(12): 6550–6555
Orrenius S, Nicotera P, Zhivotovsky B (2011). Cell death mechanisms and their implications in toxicology. Toxicol Sci, 119: 3–19
Palm W, de Lange T (2008). How shelterin protects mammalian telomeres. Annu Rev Genet, 42(1): 301–334
Pantopoulos K (2004). Iron metabolism and the IRE/IRP regulatory system: an update. Ann N Y Acad Sci, 1012(1): 1–13
Pantopoulos K, Porwal S K, Tartakoff A, Devireddy L (2012). Mechanisms of mammalian iron homeostasis. Biochemistry, 51(29): 5705–5724
Ponka P (1997). Tissue-specific regulation of iron metabolism and heme synthesis: distinct control mechanisms in erythroid cells. Blood, 89(1): 1–25
Pouillot A, Polla A, Polla B S (2013). Iron and iron chelators: a review on potential effects on skin aging. Curr Aging Sci, 6: 225–231
Rehkopf D H, DowW H, Rosero-Bixby L, Lin J, Epel E S, Blackburn E H (2013). Longer leukocyte telomere length in Costa Rica’s Nicoya Peninsula: a population-based study. Exp Gerontol, 48(11): 1266–1273
Ritchie K B, Mallory J C, Petes T D (1999). Interactions of TLC1 (which encodes the RNA subunit of telomerase), TEL1, and MEC1 in regulating telomere length in the yeast Saccharomyces cerevisiae. Mol Cell Biol, 19(9): 6065–6075
Romero A, Ramos E, de Los Ríos C, Egea J, Del Pino J, Reiter R J (2014). A review of metal-catalyzed molecular damage: protection by melatonin. J Pineal Res, 56(4): 343–370
Rouault T, Klausner R (1997). Regulation of iron metabolism in eukaryotes. Curr Top Cell Regul, 35: 1–19
Sanvisens N, Bañó M C, Huang M, Puig S (2011). Regulation of ribonucleotide reductase in response to iron deficiency. Mol Cell, 44(5): 759–769
Serrano A L, Andrés V (2004). Telomeres and cardiovascular disease: does size matter?. Circ Res, 94(5): 575–584
Shay J W, Zou Y, Hiyama E, Wright W E (2001). Telomerase and cancer. Hum Mol Genet, 10(7): 677–685
Simonet T, Zaragosi L E, Philippe C, Lebrigand K, Schouteden C, Augereau A, Bauwens S, Ye J, Santagostino M, Giulotto E, Magdinier F, Horard B, Barbry P, Waldmann R, Gilson E (2011). The human TTAGGG repeat factors 1 and 2 bind to a subset of interstitial telomeric sequences and satellite repeats. Cell Res, 21(7): 1028–1038
Smogorzewska A, van Steensel B, Bianchi A, Oelmann S, Schaefer M R, Schnapp G, de Lange T (2000). Control of human telomere length by TRF1 and TRF2. Mol Cell Biol, 20(5): 1659–1668
Soe-Lin S, Apte S S, Andriopoulos B Jr, Andrews MC, Schranzhofer M, Kahawita T, Garcia-Santos D, Ponka P (2009). Nramp1 promotes efficient macrophage recycling of iron following erythrophagocytosis in vivo. Proc Natl Acad Sci USA, 106(14): 5960–5965
Stehling Q, Vashisht A A, Mascarenhas J, Jonsson Z Q, Sharma T, NetzD J, Pierik A J, Wohlschlegel J A, Lill R (2012). MMS19 assembles iron-sulfur protein required for DNA metabolism and genomicintegrity. Science, 337: 195–199
Sun J, Yang Y, Wan K, Mao N, Yu T Y, Lin Y C, DeZwaan D C, Freeman B C, Lin J J, Lue N F, Lei M (2011). Structural bases of dimerization of yeast telomere protein Cdc13 and its interaction with the catalytic subunit of DNA polymerase α. Cell Res, 21(2): 258–274
Takata H, Kanoh Y, Gunge N, Shirahige K, Matsuura A (2004). Reciprocal association of the budding yeast ATM-related proteins Tel1 and Mec1 with telomeres in vivo. Mol Cell, 14(4): 515–522
Takata H, Tanaka Y, Matsuura A (2005). Late S phase-specific recruitment of Mre11 complex triggers hierarchical assembly of telomere replication proteins in Saccharomyces cerevisiae. Mol Cell, 17(4): 573–583
Tang D, Kang R, Zeh H J 3rd, Lotze M T (2011). High-mobility group box 1, oxidative stress, and disease. Antioxid Redox Signal, 14: 1315–1335
Tang Y D, Katz S D (2006). Anemia in chronic heart failure: prevalence, etiology, clinical correlates, and treatment options. Circulation, 113(20): 2454–2461
Torti S V, Torti F M (2013). Iron and cancer: more ore to be mined. Nat Rev Cancer, 13(5): 342–355
Turrens J F (2003). Mitochondrial formation of reactive oxygen species. J Physiol, 552(Pt 2): 335–344
Uringa E J, Youds J L, Lisaingo K, Lansdorp P M, Boulton S J (2011). RTEL1: an essential helicase for telomere maintenance and the regulation of homologous recombination. Nucleic Acids Res, 39(5): 1647–1655
van der Harst P, van Veldhuisen D J, Samani N J (2008). Expanding the concept of telomere dysfunction in cardiovascular disease. ArteriosclerThromb Vasc Biol, 28(5): 807–808
van Steensel B, de Lange T (1997). Control of telomere length by the human telomeric protein TRF1. Nature, 385(6618): 740–743
Vespa L, Couvillion M, Spangler E, Shippen D E (2005). ATM and ATR make distinct contributions to chromosome end protection and the maintenance of telomeric DNA in Arabidopsis. Genes Dev, 19(18): 2111–2115
Wang W, Deng Z, Hatcher H, Miller L D, Di X, Tesfay L, Sui G, D’Agostino R B Jr, Torti FM, Torti S V (2014). IRP2 regulates breast tumor growth. Cancer Res, 74(2): 497–507
Watson J M, Shippen D E (2007). Telomere rapid deletion regulates telomere length in Arabidopsis thaliana. Mol Cell Biol, 27(5): 1706–1715
White M F, Dillingham M S (2012). Iron-sulphur clusters in nucleic acid processing enzymes. Curr Opin Struct Biol, 22(1): 94–100
Wong L S, de Boer R A, Samani N J, van Veldhuisen D J, van der Harst P (2008). Telomere biology in heart failure. Eur J Heart Fail, 10(11): 1049–1056
Xin Z T, Beauchamp A D, Calado R T, Bradford JW, Regal J A, Shenoy A, Liang Y, Lansdorp P M, Young N S, Ly H (2007). Functional characterization of natural telomerase mutations found in patients with hematologic disorders. Blood, 109(2): 524–532
Ye H, Rouault T A (2010). Human iron-sulfur cluster assembly, cellular iron homeostasis, and disease. Biochemistry, 49(24): 4945–4956
Zavlaris M, Angelopoulou K, Vlemmas I, Papaioannou N (2009). Telomerase reverse transcriptase (TERT) expression in canine mammary tissues: a specific marker for malignancy?. Anticancer Res, 29(1): 319–325
Zhang A S (2010). Control of systemic iron homeostasis by the hemojuvelin-hepcidin axis. Adv Nutr, 1: 38–45
Zhang C (2014). Essential functions of iron-requiring proteins in DNA replication, repair and cell cycle control. Protein Cell, doi: 10.1007/s13238-014-0083-7
Zhang Y, Lyver E R, Nakamaru-Ogiso E, Yoon H, Amutha B, Lee DW, Bi E, Ohnishi T, Daldal F, Pain D, Dancis A (2008). Dre2, a conserved eukaryotic Fe/S cluster protein, functions in cytosolic Fe/S protein biogenesis. Mol Cell Biol, 28(18): 5569–5582
Zhu Z, Wilson A T, Gopalakrishna K, Brown K E, Luxon B A, Schmidt W N (2010). Hepatitis C virus core protein enhances telomerase activity in Huh7 cells. J Med Virol, 82(2): 239–248
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zhang, C. The correlation between iron homeostasis and telomere maintenance. Front. Biol. 9, 347–355 (2014). https://doi.org/10.1007/s11515-014-1327-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11515-014-1327-x